Autopsy report · NCT01504594
Autologous Stem Cells in Pediatric Patients With Dilated Cardiomyopathy
Cause of deathSlow enrollment
“Suspended because the lack of patients among the time this clinical trial was running.”
Life of this trial
- Suspended: paused, and may or may not restart.
- 10 participants planned (an estimate, not an actual count).
Vital statistics
- Status
- Suspended
- Phase
- Phase 1
- Sponsor
- Hospital Universitario Dr. Jose E. Gonzalez
- Sponsor type
- University, hospital or other
- Conditions
- Cardiomyopathy, Dilated
- Interventions
- Intracoronary autologous stem cell infusion
- Participants
- 10 (planned, not actual)
- Sites
- 1
- Countries
- Mexico
Trials that died the same way
- Anti-TRBC1 CAR-T Cell Therapy in Patients With TRBC1 Positive T Cell Malignancies
“The trial was suspended due to the inability to enroll qualified participants” - Study of the Safety and Effectiveness of Two Doses of Investigational Study Drug EVP-6124 in Subjects With Alzheimer's Disease
“Study has been suspended due to clinical hold.” - Development of a Biomarker Directed Strategy to Ameliorate Common Toxicities From Conventional Chemotherapy
“Trial has been suspended due to lack of resource and staff” - Amlexanox for Type 2 Diabetes and Obesity
“Due to limited funding, trial was suspended, intending to restart with additional funds; then preliminary results were obtained, and research moved on to placebo controlled trial. Results for both have been published.” - BEACH Trial: Bovine Early Access, Compatibility and Hemostasis Trial
“Company was sold and clinical trial was suspended then teminated”
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.